ப்ரோக்ராம்ட் இறப்பு பி.டி. தடுப்பான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nivolumab Found Effective to Treat Malignant Mesothelioma
by Angela Mohan on 
February 1, 2021 at 12:18 PM
Nivolumab found effective for relapsed malignant mesothelioma (MM), according to research presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Malignant mesothelioma is an intractable cancer, and no phase III trial has yet shown an improvement in overall survival following the standard first line chemotherapy doublet comprising pemetrexed and cisplatin or carboplatin since it was licensed in 2004.
Professor Dean Fennell, chair of Thoracic Medical Oncology at the University of Leicester in collaboration with Professor Gareth Griffiths and his team at the Southampton Clinical Trials Unit, University of Southampton, UK, presented results of the Checkpoint Blockade for Inhibition of Relapsed Mesothelioma (CONFIRM) study, funded by Cancer Research UK/Stand Up To Cancer. ....

International Association , Lung Cancer World Conference , Lung Cancer , Malignant Mesothelioma , Intractable Cancer , Programmed Death 1 Pd Inhibitor , சர்வதேச சங்கம் , நுரையீரல் புற்றுநோய் உலகம் மாநாடு , நுரையீரல் புற்றுநோய் , வீரியம் மிக்கது மீசோதெலியோமா , ப்ரோக்ராம்ட் இறப்பு பி.டி. தடுப்பான் ,